Latest from ACC 2017

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Safety of Same-Day Discharge in PCI for STEMI

Safety of Same-Day Discharge in PCI for STEMI

Researchers found that same-day discharge in PCI for non-ST-segment elevation acute coronary syndromes.

Delay Between Antiplatelet Therapy And PCI Improves Coronary Reperfusion

Delay Between Antiplatelet Therapy And PCI Improves Coronary Reperfusion

A longer wait between administration of antiplatelet therapy and primary percutaneous intervention has been linked to improved coronary reperfusion.

Analyzing Patient Heterogeneity Upon Antihypertensive Therapy Initiation to Personalize Prognosis

Analyzing Patient Heterogeneity Upon Antihypertensive Therapy Initiation to Personalize Prognosis

Patients with higher baseline blood pressure had higher 6-month combined cardiovascular disease incidence after adjustments.

Preventing Supraventricular Tachyarrythmia With Sotalol Vs Alternative Antiarrhythmics

Preventing Supraventricular Tachyarrythmia With Sotalol Vs Alternative Antiarrhythmics

Researchers conducted a meta-analysis to compare the safety and efficacy of sotalol vs amiodarone or beta-blockers to prevent supraventricular arrhythmias.

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

Evaluating Cangrelor Vs Clopidogrel In Percutaneous Coronary Intervention

Researchers studied the safety and efficacy of cangrelor in patients receiving unfractionated heparin for PCI.

Statin Eligibility Requirements In African Americans With Atherosclerosis

Statin Eligibility Requirements In African Americans With Atherosclerosis

According to ACC/AHA Guidelines presented at ACC 2017, targeted imaging should be used to personalize statin recommendation programs.

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

No differences were seen in measures of executive function between the evolocumab and placebo groups.

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

Cardiac MRI should be used to differentiate Takotsubo cardiomyopathy from similar conditions.

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.

Upcoming Meetings

Sign Up for Free e-Newsletters